Related references
Note: Only part of the references are listed.Nocturnal Glucose Control with an Artificial Pancreas at a Diabetes Camp
Moshe Phillip et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Pilot Studies of Wearable Outpatient Artificial Pancreas in Type 1 Diabetes
Claudio Cobelli et al.
DIABETES CARE (2012)
The Accuracy Benefit of Multiple Amperometric Glucose Sensors in People With Type 1 Diabetes
Jessica R. Castle et al.
DIABETES CARE (2012)
Analysis of Glucose Responses to Automated Insulin Suspension With Sensor-Augmented Pump Therapy
Trang T. Ly et al.
DIABETES CARE (2012)
Blood Glucose Control in Type 1 Diabetes With a Bihormonal Bionic Endocrine Pancreas
Steven J. Russell et al.
DIABETES CARE (2012)
Effect of Pramlintide on Prandial Glycemic Excursions During Closed-Loop Control in Adolescents and Young Adults With Type 1 Diabetes
Stuart A. Weinzimer et al.
DIABETES CARE (2012)
Feasibility Study of Automated Overnight Closed-Loop Glucose Control Under MD-Logic Artificial Pancreas in Patients with Type 1 Diabetes: The DREAM Project
Revital Nimri et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2012)
Reduction in Duration of Hypoglycemia by Automatic Suspension of Insulin Delivery: The In-Clinic ASPIRE Study
Satish Garg et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2012)
Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study
Robert H. Slover et al.
PEDIATRIC DIABETES (2012)
Accelerated Insulin Pharmacokinetics and Improved Postprandial Glycemic Control in Patients With Type 1 Diabetes After Coadministration of Prandial Insulins With Hyaluronidase
Marcus Hompesch et al.
DIABETES CARE (2011)
Safety and Efficacy of 24-h Closed-Loop Insulin Delivery in Well-Controlled Pregnant Women With Type 1 Diabetes A randomized crossover case series
Helen R. Murphy et al.
DIABETES CARE (2011)
Insulin Pump Therapy With Automated Insulin Suspension in Response to Hypoglycemia Reduction in nocturnal hypoglycemia in those at greatest risk
Pratik Choudhary et al.
DIABETES CARE (2011)
Automated Overnight Closed-Loop Glucose Control in Young Children with Type 1 Diabetes
Daniela Elleri et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2011)
Baseline Predictors of A1C Reduction in Adults Using Sensor-Augmented Pump Therapy or Multiple Daily Injection Therapy: The STAR 3 Experience
John B. Buse et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2011)
Prevention of Hypoglycemia by Using Low Glucose Suspend Function in Sensor-Augmented Pump Therapy
Thomas Danne et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2011)
Sensor-augmented pump therapy lowers HbA1c in suboptimally controlled Type 1 diabetes; a randomized controlled trial
J. Hermanides et al.
DIABETIC MEDICINE (2011)
Closed-loop insulin delivery: from bench to clinical practice
Roman Hovorka
NATURE REVIEWS ENDOCRINOLOGY (2011)
Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies
Roman Hovorka et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data
John C. Pickup et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Closed-Loop Insulin Delivery Using a Subcutaneous Glucose Sensor and Intraperitoneal Insulin Delivery Feasibility study testing a new model for the artificial pancreas
Eric Renard et al.
DIABETES CARE (2010)
Effectiveness of Continuous Glucose Monitoring in a Clinical Care Environment Evidence from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring (JDRF-CGM) trial
Stuart Weinzimer et al.
DIABETES CARE (2010)
Prevention of Nocturnal Hypoglycemia Using Predictive Alarm Algorithms and Insulin Pump Suspension
Bruce Buckingham et al.
DIABETES CARE (2010)
MD-Logic Artificial Pancreas System A pilot study in adults with type 1 diabetes
Eran Atlas et al.
DIABETES CARE (2010)
Novel Use of Glucagon in a Closed-Loop System for Prevention of Hypoglycemia in Type 1 Diabetes
Jessica R. Castle et al.
DIABETES CARE (2010)
A Bihormonal Closed-Loop Artificial Pancreas for Type 1 Diabetes
Firas H. El-Khatib et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Effect of a Local Heating Device on Insulin and Glucose Pharmacokinetic Profiles in an Open-Label, Randomized, Two-Period, One-Way Crossover Study in Patients With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion
Itamar Raz et al.
CLINICAL THERAPEUTICS (2009)
A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion
A. Liebl et al.
DIABETES OBESITY & METABOLISM (2009)
Accelerated Pharmacokinetics and Glucodynamics of Prandial Insulins Injected With Recombinant Human Hyaluronidase
Daniel E. Vaughn et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2009)
Is an Automatic Pump Suspension Feature Safe for Children with Type 1 Diabetes? An Exploratory Analysis with a Closed-Loop System
Eda Cengiz et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2009)
The stability and dissolution properties of solid glucagon/γ-cyclodextrin powder
Laura Matilainen et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Artificial pancreas: an emerging approach to treat Type 1 diabetes
Kavita Kumareswaran et al.
EXPERT REVIEW OF MEDICAL DEVICES (2009)
Functional Amyloids As Natural Storage of Peptide Hormones in Pituitary Secretory Granules
Samir K. Maji et al.
SCIENCE (2009)
Fully automated closed-loop insulin delivery versus sermautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas
Stuart A. Weinzimer et al.
DIABETES CARE (2008)
The accuracy and efficacy of Real-Time Continuous Glucose Monitoring sensor in patients with type 1 diabetes
John Mastrototaro et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2008)
Sensor-augmented insulin pump therapy: Results of the first randomized treat-to-target study
Irl B. Hirsch et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2008)
The benefit of subcutaneous glucagon during closed-loop glycemic control in rats with type 1 diabetes
W. Kenneth Ward et al.
IEEE SENSORS JOURNAL (2008)
Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Presence of diabetic ketoacidosis at diagnosis of diabetes mellitus in youth: The search for diabetes in youth study
Arleta Rewers et al.
PEDIATRICS (2008)
Feasibility of automating insulin delivery for the treatment of type 1 diabetes
Garry M. Steil et al.
DIABETES (2006)
The changing face of glucagon fibrillation: Structural polymorphism and conformational imprinting
JS Pedersen et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Pharmacokinetics of insulin aspart in obesity, renal impairment, or hepatic impairment
G Holmes et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Early glycemic control, age at onset, and development of microvascular complications in childhood-onset type 1 diabetes - A population-based study in northern Sweden
M Svensson et al.
DIABETES CARE (2004)
Closed-loop insulin delivery - the path to physiological glucose control
GM Steil et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
Mishandling of the therapeutic peptide glucagon generates cytotoxic amyloidogenic fibrils
S Onoue et al.
PHARMACEUTICAL RESEARCH (2004)
Continuous subcutaneous insulin infusion versus multiple daily injections
R Retnakaran et al.
DIABETES CARE (2004)
Evaluation of glucose controllers in virtual environment: methodology and sample application
LJ Chassin et al.
ARTIFICIAL INTELLIGENCE IN MEDICINE (2004)
Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials
J Pickup et al.
BMJ-BRITISH MEDICAL JOURNAL (2002)